Home›Stock Screener›KRM Ayurveda

KRM Ayurveda Share Price Today | Stock Price & KRM Ayurveda Share Screener

KRMAYURVED Pharmaceuticals

Track the current KRM Ayurveda share price and stock price live with TickJournal's free stock screener. Check KRMAYURVED price range for the annual price range and momentum. Use the KRM Ayurveda stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today KRM Ayurveda opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹110 and net income of ₹25, with EBITDA of ₹37, an operating margin of 33.0% and a profit margin of 22.7%.

KRM Ayurveda Market Cap ₹631.87 Cr.
KRMAYURVED P/E Ratio (TTM) 15.00
KRM Ayurveda P/B Ratio 5.66
EPS (TTM) ₹9.46
Dividend Yield -
Debt to Equity 0.23
KRMAYURVED 52 Week High -
KRM Ayurveda 52 Week Low -
Operating Margin 33.00%
Profit Margin 22.73%
KRMAYURVED Revenue (TTM) ₹110.00
EBITDA ₹37.00
Net Income ₹25.00
Total Assets ₹122.00
Total Equity ₹115.00

KRM Ayurveda Share Price Chart

Track the current stock price of KRM Ayurveda with an interactive chart. Analyse KRMAYURVED share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete KRM Ayurveda stock quote in one place.

KRM Ayurveda Company Profile - Fundamental Screener

Screen KRM Ayurveda company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for KRMAYURVED shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE1MTV01019.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE1MTV01019

KRM Ayurveda Balance Sheet Screener

Screen KRMAYURVED balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹122, up from ₹67 in 2025.

Latest statistics put total assets at ₹122 and shareholder funds at ₹115, with a leverage ratio of 0.23.

Item 2026 2025 2024 2023

Assets

Total Assets 122 67 44 40
Current Assets 94 39 21 16
Fixed Assets 26 27 23 23

Liabilities

Total Liabilities 0 0 0 0
Current Liabilities 1 19 21 18
Non-Current Liabilities 0 0 0 0

Shareholders' Equity

Total Equity 115 24 12 8
Share Capital 21 0 0 0
Reserves & Surplus 93 24 12 8

KRM Ayurveda Income Statement Screener - Profit & Revenue Analysis

Screen KRM Ayurveda income statement and profit fundamentals. Analyze KRMAYURVED quarterly results. KRM Ayurveda reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹110 and net profit was ₹25, equal to earnings per unit of ₹12.50, at an operating margin of 33%.

In that period expenses were ₹73, interest cost ₹3 and tax ₹9. The next period listed, 2026-March, shows revenue of ₹102 and net profit of ₹20.

Item None-None 2026-March 2025-March 2024-March 2023-March

Revenue and Expenses

Revenue 110 102 77 68 89
Expenses 73 71 58 60 78

Operating Costs and Margins

EBITDA 37 31 19 8 11
Operating Profit % 33.00% 30.00% 24.00% 11.00% 12.00%
Depreciation 1 1 1 1 1
Interest 3 3 3 2 0

Profit and Earnings

Profit Before Tax 34 27 15 5 10
Tax 9 7 4 1 3
Net Profit 25 20 11 3 8
EPS 12.50 9.46 747.61 2.27 5.07

KRM Ayurveda Cash Flow Screener - Liquidity Fundamentals

Screen KRMAYURVED cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹1, and net cash flow was an inflow of ₹7.

Over the same period, investing activities used ₹31 and financing activities provided ₹37.

Item 2026-March 2025-March 2024-March 2023-March

Cash from Operations and Investing

Operating Activities 1 4 -1 4
Investing Activities -31 -8 0 -23

Financing and Net Cash

Financing Activities 37 6 1 20
Net Cash Flow 7 2 0 0

KRM Ayurveda Shareholding Pattern Screener

See KRM Ayurveda shareholding pattern with promoter, FII, and DII holdings. Check KRM Ayurveda promoter holding and ownership changes for KRMAYURVED on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jan, promoters held 92.16%, foreign institutions 0.00%, domestic institutions 0.00% and the public 0.00%, spread across 64 shareholders.

The shareholder count was 64 in 2026-Jan, compared with 536 in 2026-Mar.

Item 2026-Jan 2026-Mar 2025-Sept

Promoter Holding

Promoter Holding 92.16% 69.15% 92.16%

Institutional Investors

FII Holding 0.00% 3.86% 0.00%
DII Holding 0.00% 3.34% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00%
Public Holding 0.00% 14.87% 0.00%
Other Holding 7.84% 8.78% 7.84%
Shareholder Count 64 536 54

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by KRM Ayurveda. KRM Ayurveda dividend yield can be compared with peers and other stocks in the market.

No dividends declared by KRM Ayurveda.

KRM Ayurveda Stock Index Membership - Nifty & Sensex

See which indices include KRM Ayurveda stock. Check KRMAYURVED index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

KRM Ayurveda is not part of any tracked indices.
Only major market indices are tracked in our system.

KRM Ayurveda Market Events Screener - Corporate Actions

Get KRM Ayurveda corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check KRM Ayurveda stock events that may affect KRMAYURVED share price, along with derivatives, futures and options activity and sector gainers.

2 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated August 10, 2026, with a record date of August 10, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-08-10 2026-08-10 Quarterly Result Announcement NA 3.07%
2026-05-01 2026-05-01 Quarterly Result Announcement NA 10.51%

KRM Ayurveda Competitors Screener - Peer Stocks Comparison

Screen KRMAYURVED competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 435,863 36.83 61,674 12.69% 11,565 38.95
Divis Laboratories 246,660 86.00 11,067 13.95% 2,568 53.27
Torrent Pharmaceuticals 182,577 86.72 13,886 20.34% 2,138 42.82
Zydus Life Science 115,910 25.96 27,658 17.64% 5,026 51.33
Cipla 108,738 33.29 29,045 2.24% 3,870 35.23
Laurus Labs 106,982 98.39 6,868 22.01% 890 58.13
Mankind Pharma 103,418 50.84 14,636 14.85% 1,938 59.40
Dr Reddys Laboratories 102,916 32.77 35,059 3.90% 4,158 62.37
Aurobindo Pharma 96,203 26.41 34,145 5.56% 3,503 49.32
Lupin 92,839 16.97 29,039 26.75% 5,356 31.32

KRM Ayurveda Company Announcements - News & Reports Screener

Screen KRMAYURVED latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

No company announcements available.

Frequently Asked Questions

How is the company valued right now?

The P/E ratio is 15.00 and the P/B ratio is 5.66, with earnings per unit of ₹9.46. Market capitalisation stands at ₹631.87 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on October 5, 2026. This page covers 4 balance sheet periods, 5 income statement periods, 4 cash flow years and 3 shareholding periods. Information is provided for research and is not investment advice.